Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001306923-21-000018
Filing Date
2021-02-16
Accepted
2021-02-16 16:41:21
Documents
2

Document Format Files

Seq Description Document Type Size
1 Karyopharm_13G_A5.txt SC 13G/A 10224
2 Karyopharm_13G_A5.pdf SC 13G/A 194275
  Complete submission text file 0001306923-21-000018.txt   279562
Mailing Address 470 UNIVERSITY AVE PALO ALTO CA 94301
Business Address 470 UNIVERSITY AVE PALO ALTO CA 94301 650-325-0772
Palo Alto Investors LP (Filed by) CIK: 0001306923 (see all company filings)

EIN.: 770558164 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Subject) CIK: 0001503802 (see all company filings)

EIN.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87705 | Film No.: 21639765
SIC: 2834 Pharmaceutical Preparations